These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15019164)
1. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II. Lund P; Schubert D; Niketeghad F; Schirmacher P Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164 [TBL] [Abstract][Full Text] [Related]
2. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Huynh H; Chow PK; Ooi LL; Soo KC Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812 [TBL] [Abstract][Full Text] [Related]
3. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines. Alexia C; Lasfer M; Groyer A Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801 [TBL] [Abstract][Full Text] [Related]
4. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells. Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas. Zvibel I; Brill S; Reid LM J Cell Physiol; 1995 Jan; 162(1):36-43. PubMed ID: 7529237 [TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387 [TBL] [Abstract][Full Text] [Related]
8. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183 [TBL] [Abstract][Full Text] [Related]
9. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802 [TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627 [TBL] [Abstract][Full Text] [Related]
11. [Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?]. Nussbaum T; Vreden S; Farsad M; Schirmacher P; Breuhahn K Verh Dtsch Ges Pathol; 2005; 89():254-60. PubMed ID: 18035699 [TBL] [Abstract][Full Text] [Related]
12. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells. Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687 [TBL] [Abstract][Full Text] [Related]
13. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines. Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007 [TBL] [Abstract][Full Text] [Related]
15. Effects of insulin-like growth factor-binding protein 2 and an IGF-type I receptor-blocking antibody on apoptosis in human teratocarcinoma cells in vitro. Granerus M; Engström W Cell Biol Int; 2001; 25(8):825-8. PubMed ID: 11482908 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-II: a novel autocrine growth factor modulating the apoptosis and maturation of umbilical cord blood erythroid progenitors. Nagatomo T; Muta K; Ohga S; Ochiai M; Ohshima K; Hara T Exp Hematol; 2008 Apr; 36(4):401-11. PubMed ID: 18261839 [TBL] [Abstract][Full Text] [Related]
17. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. Lamm GM; Christofori G Cancer Res; 1998 Feb; 58(4):801-7. PubMed ID: 9485038 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor II induces apoptosis in osteoblasts. Gronowicz GA; McCarthy MB; Zhang H; Zhang W Bone; 2004 Sep; 35(3):621-8. PubMed ID: 15336597 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Breuhahn K; Longerich T; Schirmacher P Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by insulin or insulin-like growth factor-I. Fukaya Y; Yamaguchi M J Cell Biochem; 2005 Sep; 96(1):145-54. PubMed ID: 15880694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]